Ohio Public Employees Retirement System (OPERS)
NRIX icon

Ohio Public Employees Retirement System (OPERS)’s Nurix Therapeutics NRIX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$421K Hold
27,150
– – ﹤0.01% 1523
2025
Q4 		$515K Buy
+27,150
New +$390K ﹤0.01% 1500
2024
Q3 		– Sell
-22,138
Closed -$462K – 2322
2024
Q2 		$462K Sell
22,138
-28,700
-56% -$447K ﹤0.01% 1285
2024
Q1 		$747K Buy
50,838
+1,820
+4% +$19.6K ﹤0.01% 1179
2023
Q4 		$506K Buy
49,018
+12,880
+36% +$88.3K ﹤0.01% 1264
2023
Q3 		$284K Sell
36,138
-49,848
-58% -$455K ﹤0.01% 1318
2023
Q2 		$859K Sell
85,986
-5,493
-6% -$56K ﹤0.01% 1185
2023
Q1 		$812K Buy
91,479
+7,764
+9% +$80.9K ﹤0.01% 1195
2022
Q4 		$919K Buy
83,715
+8,976
+12% +$108K ﹤0.01% 1185
2022
Q3 		$974K Buy
74,739
+16,087
+27% +$255K ﹤0.01% 1219
2022
Q2 		$743K Buy
58,652
+15,697
+37% +$178K ﹤0.01% 1296
2022
Q1 		$602K Buy
42,955
+14,164
+49% +$251K ﹤0.01% 1320
2021
Q4 		$833K Hold
28,791
– – ﹤0.01% 1277
2021
Q3 		$863K Hold
28,791
– – ﹤0.01% 1271
2021
Q2 		$764K Hold
28,791
– – ﹤0.01% 1289
2021
Q1 		$895K Buy
+28,791
New +$1.09M ﹤0.01% 1245

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s NRIX Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) held its Nurix Therapeutics (NRIX) position steady in Q1 2026 at 27,150 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

Ohio Public Employees Retirement System (OPERS) first reported a position in NRIX in Q1 2021 and has held it in 16 quarters since. The position peaked at $974K in Q3 2022. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 27,150 shares of Nurix Therapeutics worth $421K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) left its Nurix Therapeutics share count unchanged in Q1 2026.
  • Nurix Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1523 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Nurix Therapeutics position peaked at $974K in Q3 2022.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.